Bempedoic acid/Ezetimibe Prescribing at SAFFRON GROUP PRACTICE
Lipid-regulating drugs | Cardiovascular System
Items (12m)
202
Total Quantity
5,824
NHS Cost
£11.0K
vs National Avg
+230.8%
SAFFRON GROUP PRACTICE prescribed 202 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £10,957 to the NHS. This is 230.8% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
9
Jun 2026
7
Jun 2026
14
Jun 2026
10
Jun 2026
15
Jun 2026
16
Jun 2026
16
Jun 2026
20
Jun 2026
24
Jun 2026
20
Jun 2026
24
Jun 2026
27
Prescribing Details
| Total Items | 202 |
|---|---|
| Total Quantity | 5,824 |
| Total NHS Cost | £10,957 |
| Presentations | 2 different forms |
| vs National Average | +230.8% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 202 items |
|---|---|
| National average per practice | 61 items |
| Difference | +230.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.